Legal & General Group Plc - INFINITY PHARMACEUTICALS INC ownership

INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 97 filers reported holding INFINITY PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.32 and the average weighting 0.0%.

Quarter-by-quarter ownership
Legal & General Group Plc ownership history of INFINITY PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$4,000
-60.0%
6,988
-22.7%
0.00%
Q1 2022$10,000
-50.0%
9,0380.0%0.00%
Q4 2021$20,000
-35.5%
9,0380.0%0.00%
Q3 2021$31,000
+14.8%
9,0380.0%0.00%
Q2 2021$27,000
-95.1%
9,038
-97.4%
0.00%
Q2 2017$548,000
+1145.5%
349,346
+2430.0%
0.00%
Q1 2017$44,000
+76.0%
13,808
-25.5%
0.00%
Q4 2016$25,000
+127.3%
18,534
+154.6%
0.00%
Q3 2016$11,000
+10.0%
7,2790.0%0.00%
Q2 2016$10,000
-74.4%
7,2790.0%0.00%
Q1 2016$39,000
-30.4%
7,2790.0%0.00%
Q4 2015$56,000
-5.1%
7,2790.0%0.00%
Q3 2015$59,000
-22.4%
7,2790.0%0.00%
Q2 2015$76,000
-28.3%
7,2790.0%0.00%
Q1 2015$106,000
-14.5%
7,2790.0%0.00%
Q4 2014$124,000
+18.1%
7,279
-5.0%
0.00%
Q3 2014$105,0007,6590.00%
Other shareholders
INFINITY PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
BVF INC/IL 7,866,108$25,408,0004.32%
Nine Chapters Capital Management LLC 91,500$296,0000.40%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,969,225$6,361,0000.24%
Orbimed Advisors 3,250,300$10,498,0000.12%
PINNACLE ASSOCIATES LTD 1,306,679$4,221,0000.08%
PLATINUM INVESTMENT MANAGEMENT LTD 810,232$2,617,0000.07%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 270,417$873,0000.06%
Rock Springs Capital Management LP 270,000$872,0000.05%
ALGERT GLOBAL LLC 39,876$129,0000.04%
JACOBS LEVY EQUITY MANAGEMENT, INC 391,671$1,265,0000.03%
View complete list of INFINITY PHARMACEUTICALS INC shareholders